Literature DB >> 21059642

Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3.

Hong Guo1, Alan D Friedman.   

Abstract

RUNX1 regulates formation of the definitive hematopoietic stem cell and its subsequent lineage maturation, and mutations of RUNX1 contribute to leukemic transformation. Phosphorylation of Ser-48, Ser-303, and Ser-424 by cyclin-dependent kinases (cdks) increases RUNX1 trans-activation activity without perturbing p300 interaction. We now find that endogenous RUNX1 interacts with endogenous HDAC1 or HDAC3. Mutation of the three RUNX1 serines to aspartic acid reduces co-immunoprecipitation with HDAC1 or HDAC3 when expressed in 293T cells; mutation of these three serines to alanine increases HDAC interaction, and mutation of each serine individually to aspartic acid also reduces these interactions. GST-RUNX1 isolated from bacterial extracts bound in vitro translated HDAC1 or HDAC3, and these interactions were weakened by mutation of Ser-48, Ser-303, and Ser-424 to aspartic acid. The ability of RUNX1 phosphorylation and not only serine to aspartic acid conversion to reduce HDAC1 binding was demonstrated using wild-type GST-RUNX1 phosphorylated in vitro using cdk1/cyclinB and by exposure of 293T cells transduced with RUNX1 and HDAC1 to roscovitine, a cdk inhibitor. Finally, RUNX1 or RUNX1(tripleD), in which Ser-48, Ser-303, and Ser-424 are mutated to aspartic acid, stimulated proliferation of transduced, lineage-negative murine marrow progenitors more potently than did RUNX1(tripleA), in which these serines are mutated to alanine, suggesting that stimulation of RUNX1 trans-activation by cdk-mediated reduction in HDAC interaction increases marrow progenitor cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059642      PMCID: PMC3012976          DOI: 10.1074/jbc.M110.149013

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  CBFbeta-SMMHC slows proliferation of primary murine and human myeloid progenitors.

Authors:  J D'Costa; S Chaudhuri; C I Civin; A D Friedman
Journal:  Leukemia       Date:  2005-06       Impact factor: 11.528

2.  Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6.

Authors:  C W Wong; M L Privalsky
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

3.  CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells.

Authors:  W Cao; M Britos-Bray; D F Claxton; C A Kelley; N A Speck; P P Liu; A D Friedman
Journal:  Oncogene       Date:  1997-09       Impact factor: 9.867

4.  kat: a high-efficiency retroviral transduction system for primary human T lymphocytes.

Authors:  M H Finer; T J Dull; L Qin; D Farson; M R Roberts
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

5.  c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoprotein.

Authors:  Florence Bernardin; Yandan Yang; Curt I Civin; Alan D Friedman
Journal:  Cancer Biol Ther       Date:  2002 Sep-Oct       Impact factor: 4.742

6.  AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.

Authors:  Motoshi Ichikawa; Takashi Asai; Toshiki Saito; Sachiko Seo; Ieharu Yamazaki; Tetsuya Yamagata; Kinuko Mitani; Shigeru Chiba; Seishi Ogawa; Mineo Kurokawa; Hisamaru Hirai
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

7.  AML1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression.

Authors:  Florence Bernardin-Fried; Tanawan Kummalue; Suzanne Leijen; Michael I Collector; Katya Ravid; Alan D Friedman
Journal:  J Biol Chem       Date:  2004-01-27       Impact factor: 5.157

8.  The core binding factor (CBF) alpha interaction domain and the smooth muscle myosin heavy chain (SMMHC) segment of CBFbeta-SMMHC are both required to slow cell proliferation.

Authors:  W Cao; N Adya; M Britos-Bray; P P Liu; A D Friedman
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

9.  Rescue of defective mitogenic signaling by D-type cyclins.

Authors:  M F Roussel; A M Theodoras; M Pagano; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

10.  The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.

Authors:  Kristie L Durst; Bart Lutterbach; Tanawan Kummalue; Alan D Friedman; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

View more
  28 in total

Review 1.  Hdac-mediated control of endochondral and intramembranous ossification.

Authors:  Elizabeth W Bradley; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.

Authors:  John Anto Pulikkan; Mahesh Hegde; Hafiz Mohd Ahmad; Houda Belaghzal; Anuradha Illendula; Jun Yu; Kelsey O'Hagan; Jianhong Ou; Carsten Muller-Tidow; Scot A Wolfe; Lihua Julie Zhu; Job Dekker; John Hackett Bushweller; Lucio Hernán Castilla
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

Review 3.  Posttranslational modifications of RUNX1 as potential anticancer targets.

Authors:  S Goyama; G Huang; M Kurokawa; J C Mulloy
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

4.  Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML.

Authors:  Chun Guo; Jian Li; Nickolas Steinauer; Madeline Wong; Brent Wu; Alexandria Dickson; Markus Kalkum; Jinsong Zhang
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

5.  Tyrosyl phosphorylation toggles a Runx1 switch.

Authors:  Benjamin G Neel; Nancy A Speck
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

Review 6.  New roles for cyclin-dependent kinases in T cell biology: linking cell division and differentiation.

Authors:  Andrew D Wells; Peter A Morawski
Journal:  Nat Rev Immunol       Date:  2014-03-07       Impact factor: 53.106

7.  Identification of the Regulatory Elements and Target Genes of Megakaryopoietic Transcription Factor MEF2C.

Authors:  Xianguo Kong; Lin Ma; Edward Chen; Chad A Shaw; Leonard C Edelstein
Journal:  Thromb Haemost       Date:  2019-02-07       Impact factor: 5.249

8.  Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.

Authors:  Dan Wu; Toshinori Ozaki; Yukari Yoshihara; Natsumi Kubo; Akira Nakagawara
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

9.  Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.

Authors:  Marinus R Heideman; Roel H Wilting; Eva Yanover; Arno Velds; Johann de Jong; Ron M Kerkhoven; Heinz Jacobs; Lodewyk F Wessels; Jan-Hermen Dannenberg
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

10.  Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis.

Authors:  Wan Yee Leong; Hong Guo; Ou Ma; Hui Huang; Alan B Cantor; Alan D Friedman
Journal:  J Biol Chem       Date:  2015-11-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.